Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karel Ulbrich

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Advanced Drug Delivery Reviews|April 7, 2004
Polymeric anticancer drugs with pH-controlled activationKarel Ulbrich, Vladimír Subr
Advanced Drug Delivery Reviews|November 26, 2009
Structural and chemical aspects of HPMA copolymers as drug carriersKarel Ulbrich, Vladimír Subr
Advanced Drug Delivery Reviews|December 17, 2009
HPMA copolymers: 30 years of advancesTwan Lammers, Karel Ulbrich
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2009
HPMA-based polymer conjugates with drug combinationHana Krakovicová, Tomás Etrych, Karel Ulbrich
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 16, 2005
Polymeric micellar pH-sensitive drug delivery system for doxorubicinMartin Hrubý, Cestmír Konák, Karel Ulbrich
Biomacromolecules|January 10, 2006
Coating of DNA/poly(L-lysine) complexes by covalent attachment of poly[N-(2-hydroxypropyl)methacrylamide]Vladimír Subr, Cestmír Konák, Richard Laga, et al.
Macromolecular Bioscience|August 15, 2017
HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug ReleasePetr Chytil, Eva Koziolová, Tomáš Etrych, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2007
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapyTomás Etrych, Tomás Mrkvan, Blanka Ríhová, et al.
Nano Letters|January 28, 2009
Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapyGrégory F Schneider, Vladimir Subr, Karel Ulbrich, et al.
Pharmaceutical Research|November 19, 2003
Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugsMarkéta Jelínková, Jirí Strohalm, Tomás Etrych, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Advanced Drug Delivery Reviews|April 7, 2004
Polymeric anticancer drugs with pH-controlled activationKarel Ulbrich, Vladimír Subr
Advanced Drug Delivery Reviews|November 26, 2009
Structural and chemical aspects of HPMA copolymers as drug carriersKarel Ulbrich, Vladimír Subr
Advanced Drug Delivery Reviews|December 17, 2009
HPMA copolymers: 30 years of advancesTwan Lammers, Karel Ulbrich
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2009
HPMA-based polymer conjugates with drug combinationHana Krakovicová, Tomás Etrych, Karel Ulbrich
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 16, 2005
Polymeric micellar pH-sensitive drug delivery system for doxorubicinMartin Hrubý, Cestmír Konák, Karel Ulbrich
Biomacromolecules|January 10, 2006
Coating of DNA/poly(L-lysine) complexes by covalent attachment of poly[N-(2-hydroxypropyl)methacrylamide]Vladimír Subr, Cestmír Konák, Richard Laga, et al.
Macromolecular Bioscience|August 15, 2017
HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug ReleasePetr Chytil, Eva Koziolová, Tomáš Etrych, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2007
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapyTomás Etrych, Tomás Mrkvan, Blanka Ríhová, et al.
Nano Letters|January 28, 2009
Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapyGrégory F Schneider, Vladimir Subr, Karel Ulbrich, et al.
Pharmaceutical Research|November 19, 2003
Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugsMarkéta Jelínková, Jirí Strohalm, Tomás Etrych, et al.
Pageof 12